BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9173362)

  • 1. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
    Milner RJ; Pearson J; Nesbit JW; Close P
    Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods in pathology. Identification of T-cell lymphomas in paraffin-embedded tissues using polyclonal anti-CD3 antibody: comparison with frozen section immunophenotyping and genotypic analysis.
    Anderson C; Rezuke WN; Kosciol CM; Pastuszak WT; Cartun RW
    Mod Pathol; 1991 May; 4(3):358-62. PubMed ID: 1829834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
    Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
    Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
    Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and immunophenotypical features of canine intravascular lymphoma (malignant angioendotheliomatosis).
    McDonough SP; Van Winkle TJ; Valentine BA; vanGessel YA; Summers BA
    J Comp Pathol; 2002 May; 126(4):277-88. PubMed ID: 12056776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
    Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
    J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology.
    Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M
    Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
    Cartun RW; Coles FB; Pastuszak WT
    Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
    Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
    Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine lymphomas: a morphological and immunohistochemical study of 55 cases, with observations on p53 immunoexpression.
    Sueiro FA; Alessi AC; Vassallo J
    J Comp Pathol; 2004; 131(2-3):207-13. PubMed ID: 15276860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
    Linder J; Ye Y; Armitage JO; Weisenburger DD
    Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the boxer breed.
    Lurie DM; Milner RJ; Suter SE; Vernau W
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):102-10. PubMed ID: 18579219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas.
    Sözmen M; Tasca S; Carli E; De Lorenzi D; Furlanello T; Caldin M
    J Vet Diagn Invest; 2005 Jul; 17(4):323-30. PubMed ID: 16130989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
    Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
    Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of two monoclonal antibodies (FB1 and FB21) useful for the identification of human B lymphocytes in formalin-fixed, paraffin-embedded tissues.
    Nozawa Y; Abe M; Ohno H; Fukuhara S; Wakasa H
    J Pathol; 1994 Aug; 173(4):347-54. PubMed ID: 7965394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E; Wisman P; Moore PF; van Heerde P
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
    Ramos-Vara JA; Miller MA; Valli VE
    Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping.
    Guija de Arespacochaga A; Schwendenwein I; Weissenböck H
    J Comp Pathol; 2007; 136(2-3):186-92. PubMed ID: 17416237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.